Načítá se...
Progressive Multifocal Leukoencephalopathy after Treatment with Nivolumab
Progressive multifocal leukoencephalopathy (PML) is increasingly being reported in patients undergoing immunotherapy. We report a case of progressive multifocal leukoencephalopathy after treatment with nivolumab, a PD-1 blocker that is used to restore impaired T-cell responses in patients with cance...
Uloženo v:
| Vydáno v: | Emerg Infect Dis |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Centers for Disease Control and Prevention
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6056118/ https://ncbi.nlm.nih.gov/pubmed/30016251 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3201/eid2408.180460 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|